United States· US:42515-002_f3d13c93-5fce-43db-b25f-8e1c8cd1dfb8
IXIARO
A medicinal product containing japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated), registered in United States by Valneva Scotland Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Manufacturer
- Valneva Scotland Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc114251500201.5 mL in 1 SYRINGE (42515-002-01)
- ndc1142515-002-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIxiaro vaccine suspension for injection 0.5ml pre-filled syringesValneva UK Ltd
- CanadaIXIAROVALNEVA AUSTRIA GMBH
- FranceIXIARO, suspension injectable. Vaccin de l'encéphalite japonaise (inactivé, adsorbé)VALNEVA AUSTRIA (AUTRICHE)
- IrelandIxiaro 6 AU Suspension for injectionIntercell Austria AG
- IcelandIxiaroValneva Austria GmbH
- NetherlandsIxiaro, suspensie voor injectieIntercell Austria AG
- PolandIxiaroValneva Austria GmbH
- BelgiumIxiaroValneva Austria
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2571a1e-a20c-40ff-b1ad-6b091ea6563a GET /v1/drugs/b2571a1e-a20c-40ff-b1ad-6b091ea6563a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR",
"source": "ndc",
"strength": "6",
"substance": "JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"productndc": "42515-002",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "[arb'U]/.5mL",
"application_number": "BLA125280",
"marketing_category": "BLA"
}See everything about japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.